Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Operating expenses

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Dec 31, 202531,910-3.20%
Dec 31, 202432,966-0.82%
Dec 31, 202333,239-3.52%
Dec 31, 202234,452+22.89%
Dec 31, 202128,035+47.81%
Sep 30, 202118,966+67.84%
Sep 30, 202011,300-35.12%
Sep 30, 201917,418+41.22%
Sep 30, 201812,334+33.22%
Sep 30, 20179,258+24.39%
Sep 30, 20167,443+110.07%
Sep 30, 20153,543+107.63%
Sep 30, 20141,706

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat